Inventor · disambiguated record
Siok Ping Yeo
Also filed as: YEO SIOK PING
23 granted patents·3 pending applications·122 citations·filing 2013–2023
95Inventor score
Files withAGENCY SCIENCE TECH & RES26
Top patents by PatentIndex Score
26 records- 0195US9758583B2Anti-CTLA-4 antibodiesAGENCY SCIENCE TECH & RES·Filed 2017·Granted Sep 12, 2017·48 cites·17 claims
- 0294US9789183B1Anti-PD-L1 antibodiesAGENCY SCIENCE TECH & RES·Filed 2017·Granted Oct 17, 2017·13 cites·20 claims
- 0392US10472423B2IL2Rbeta/common gamma chain antibodiesAGENCY SCIENCE TECH & RES·Filed 2018·Granted Nov 12, 2019·7 cites·5 claims
- 0490US10696747B2IL2R common gamma chain antibodiesAGENCY SCIENCE TECH & RES·Filed 2018·Granted Jun 30, 2020·4 cites·5 claims
- 0590US10517949B2Anti-PD-L1 antibodiesAGENCY SCIENCE TECH & RES·Filed 2016·Granted Dec 31, 2019·8 cites·12 claims
- 0690US9771425B2Anti-PD-1 antibodiesAGENCY SCIENCE TECH & RES·Filed 2017·Granted Sep 26, 2017·10 cites·20 claims
- 0788US10246512B2IL-2R beta/common gamma chain antibodiesAGENCY SCIENCE TECH & RES·Filed 2018·Granted Apr 2, 2019·6 cites·6 claims
- 0886US10919962B2Method of reducing tumor growth with IL-1beta neutralizing human monoclonal antibodiesAGENCY SCIENCE TECH & RES·Filed 2018·Granted Feb 16, 2021·4 cites·14 claims
- 0984US12472252B2Anti-PD-L1 antibodiesAGENCY SCIENCE TECH & RES·Filed 2022·Granted Nov 18, 2025·0 cites·19 claims
- 1084US10259874B2Anti-TIM-3 antibodiesAGENCY SCIENCE TECH & RES·Filed 2015·Granted Apr 16, 2019·6 cites·13 claims
- 1184US10167338B2Method of treating cancer using IL2R beta/common gamma chain antibodiesAGENCY SCIENCE TECH & RES·Filed 2016·Granted Jan 1, 2019·4 cites·2 claims
- 1284US10167335B2IL-1β neutralizing human monoclonal antibodiesAGENCY SCIENCE TECH & RES·Filed 2013·Granted Jan 1, 2019·6 cites·17 claims
- 1382US11534489B2Anti-PD-L1 antibodiesAGENCY SCIENCE TECH & RES·Filed 2019·Granted Dec 27, 2022·1 cites·9 claims
- 1482US10472421B2Method for expansion of a population of cells with IL2R beta/common gamma chain antibodiesAGENCY SCIENCE TECH & RES·Filed 2016·Granted Nov 12, 2019·3 cites·7 claims
- 1574US11912761B2IL-1β neutralizing human monoclonal antibodiesAGENCY SCIENCE TECH & RES·Filed 2021·Granted Feb 27, 2024·0 cites·18 claims
- 1674US11702471B2IL-1β neutralizing human monoclonal antibodiesAGENCY SCIENCE TECH & RES·Filed 2021·Granted Jul 18, 2023·0 cites·20 claims
- 1773US11780913B2IL-1β neutralizing human monoclonal antibodiesAGENCY SCIENCE TECH & RES·Filed 2020·Granted Oct 10, 2023·0 cites·9 claims
- 1871US2024052046A1Il2rbeta/common gamma chain antibodiesAGENCY SCIENCE TECH & RES·Filed 2023·Application pending·0 cites
- 1970US10280224B2Anti-PD-1 antibodiesAGENCY SCIENCE TECH & RES·Filed 2015·Granted May 7, 2019·1 cites·16 claims
- 2067US11072659B2Anti-PD-1 antibodiesAGENCY SCIENCE TECH & RES·Filed 2019·Granted Jul 27, 2021·0 cites·20 claims
- 2167US10435466B2Anti-TIM-3 antibodiesAGENCY SCIENCE TECH & RES·Filed 2015·Granted Oct 8, 2019·1 cites·9 claims
- 2264US11739157B2IL2Rbeta/common gamma chain antibodiesAGENCY SCIENCE TECH & RES·Filed 2018·Granted Aug 29, 2023·0 cites·15 claims
- 2358US11142574B2Anti-TIM-3 antibodiesAGENCY SCIENCE TECH & RES·Filed 2019·Granted Oct 12, 2021·0 cites·12 claims
- 2457US11267887B2Anti-CTLA-4 antibodiesAGENCY SCIENCE TECH & RES·Filed 2017·Granted Mar 8, 2022·0 cites·14 claims
- 2551US2020055935A1Anti-TIM-3 AntibodiesAGENCY SCIENCE TECH & RES·Filed 2019·Application pending·0 cites
- 2637US2019040136A1Anti-lag-3 antibodiesAGENCY SCIENCE TECH & RES·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →